Published online Dec 27, 2020. doi: 10.4254/wjh.v12.i12.1267
Peer-review started: July 17, 2020
First decision: September 21, 2020
Revised: October 3, 2020
Accepted: October 27, 2020
Article in press: October 27, 2020
Published online: December 27, 2020
Processing time: 153 Days and 10.4 Hours
Cirrhosis is a leading cause of death worldwide and ascites is one of the most common complications of cirrhosis. Patients are frequently admitted to hospital, placing significant burden on the healthcare system.
Data regarding the optimal time of paracentesis and outcomes among patients with cirrhosis and ascites are scarce in the literature.
The aim of this study was to assess the outcomes of patients with cirrhosis and ascites who underwent paracentesis within 12 h after admission compared to patients who underwent paracentesis later than 12 h.
This was a retrospective study of 185 patients with cirrhosis and ascites who underwent paracentesis. The early paracentesis group was defined as paracentesis performed < 12 h after admission (65 patients) and the delayed paracentesis group was defined as paracentesis performed > 12 h after admission (120 patients). Complications of cirrhosis occurring during hospitalization were assessed and compared between the groups.
Significantly more patients in the delayed paracentesis group than in the early paracentesis group developed hepatic encephalopathy, hepato-renal syndrome and infections during hospitalization. There were no statistically significant differences in the occurrence of spontaneous bacterial peritonitis and upper gastrointestinal bleeding between the two groups. Length of stay was shorter and in-hospital mortality was lower in the early paracentesis group. Patients from the delayed paracentesis group had a higher risk of developing complications during hospitalization.
Early paracentesis (within 12 h after admission) is associated with fewer complications of cirrhosis, lower in-hospital mortality and shorter length of stay.
Early paracentesis could be a new inpatient quality metric among patients hospitalized with cirrhosis and ascites and deserves to be investigated further in larger studies.